Compound ID | 937
Synonym(s): A 56619
Class: Fluoroquinolone
Spectrum of activity: | Gram-positive & Gram-negative |
Institute where first reported: | Abbott Laboratories; AbbieVie |
Highest developmental phase: | Phase 2 |
Development status: | Inactive |
Reason Dropped: | A number of frequent side effects: appetite disorders; CNS disorders; dizziness; drowsiness; headache; insomnia; nausea; vision disorders; vomiting |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/56206 |
Guide to Pharmacology: | difloxacin |
Citation: | https://journals.asm.org/doi/10.1128/aac.28.4.514 |